G

Global Blood Therapeutics Inc
F:G5B

Watchlist Manager
Global Blood Therapeutics Inc
F:G5B
Watchlist
Price: 68.4 EUR -1.27% Market Closed
Market Cap: 4.6B EUR

Intrinsic Value

G5B price has not been updated for more than 3 months. This may indicate that the stock has been delisted.

There is not enough data to reliably calculate the intrinsic value of G5B.

The Intrinsic Value is calculated as the average of DCF and Relative values:

G5B Intrinsic Value
Not Available
Base Case Scenario
Compare G5B to

Fundamental Analysis

Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about G5B?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Global Blood Therapeutics Inc

Current Assets 640m
Cash & Short-Term Investments 517.2m
Receivables 29.8m
Other Current Assets 93.1m
Non-Current Assets 230.4m
Long-Term Investments 146.9m
PP&E 78.9m
Other Non-Current Assets 4.6m
Current Liabilities 93.1m
Accounts Payable 8.3m
Accrued Liabilities 84.6m
Other Current Liabilities 260k
Non-Current Liabilities 659m
Long-Term Debt 581.9m
Other Non-Current Liabilities 77m
Efficiency

Free Cash Flow Analysis
Global Blood Therapeutics Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Global Blood Therapeutics Inc

Revenue
234.9m USD
Cost of Revenue
-4.5m USD
Gross Profit
230.4m USD
Operating Expenses
-529.7m USD
Operating Income
-299.2m USD
Other Expenses
-23.2m USD
Net Income
-322.5m USD
Fundamental Scores

G5B Profitability Score
Profitability Due Diligence

Global Blood Therapeutics Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin
Strong 3Y Average Gross Margin
ROE is Increasing
Declining Gross Margin
hidden
Profitability
Score

Global Blood Therapeutics Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

G5B Solvency Score
Solvency Due Diligence

Global Blood Therapeutics Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Positive Net Debt
Long-Term Solvency
High D/E
hidden
Solvency
Score

Global Blood Therapeutics Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

G5B Price Targets Summary
Global Blood Therapeutics Inc

There are no price targets for G5B.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for G5B is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
Lowest
Average
Highest
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y